Company / Capital Expenditures
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$2.7M
FY2025
5-year range
$2.7M / $16.8M
FY2021-FY2025
Trend
-56.1%
vs FY2024
Sector context
#138 of 151
Health Care
What the data says
Among 151 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 9% for capital expenditures. Capital Expenditures has declined for 3 consecutive years, from $17M in FY2022 to $3M in FY2025.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +21.2%.
Declined from $9M to $3M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -45.5%
- 5-Year CAGR
- +21.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 151This company $2.7M Sector average $271.7M
▼
-99.0% below sector average
Key checks
Key Insights
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s capital expenditures has declined for 3 consecutive years.
- 5-year CAGR of +21.2%, indicating consistent growth.
- In FY2025, capital expenditures decreased 56.1% year-over-year.
- Ranks #138 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.7M | -56.1% |
| FY2024 | $6.2M | -30.0% |
| FY2023 | $8.8M | -47.2% |
| FY2022 | $16.8M | +182.4% |
| FY2021 | $5.9M | +470.8% |
| FY2020 | $1.0M | -63.4% |
| FY2019 | $2.8M | +53.0% |
| FY2018 | $1.9M | -82.2% |
| FY2017 | $10.4M | +27.1% |
| FY2016 | $8.2M | +802.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026